How age, gender and medical specialty affect a physician's risk of being sued

New data from the American Medical Association reveal that nearly one-third of physicians in the United States have been sued during their medical career. 

The new analysis also indicates that there are several factors that contribute to a physician’s likelihood of being sued while practicing medicine, including age, medical specialty and gender.  

Of physicians age 55 and older, nearly half (46.8%) have been sued at some point. In comparison, this was the case in just 9.5% of those under the age of 40.  

Medical specialty also appears to play a large role in whether a patient will seek legal action against a provider. The report indicates that obstetricians/gynecologists (OB-GYNs), general surgeons, other surgeons and orthopedic surgeons are at the greatest risk of litigation, with 62.4%, 59.3%, 55.5% and 47.2% having already been sued at some point in their medical career. Allergists/immunologists and hematologists/oncologists recorded the lowest risk. 

Men are also more likely to face lawsuits; Based on the report, men recorded 75 claims per 100 physicians, while women represented a significantly lower proportion at 42 claims per 100 female physicians. Just under 25% of women included in the analysis reported being sued compared to 36.8% of men. 

While the report suggests that physicians—especially male surgeons over the age of 55—face serious risk of having a lawsuit filed against them, AMA President Jack Resneck Jr., MD, had some reassurance to offer providers. 

“Even the most highly qualified and competent physicians in the U.S. may face a medical liability claim in their careers, however, getting sued is not indicative of medical errors,” Resneck said in a release. "When physicians are sued, two-thirds of civil liability claims are dropped, dismissed or withdrawn without a finding of fault. When claims proceed to trial and are decided by a verdict, the defendants prevail in nearly 9 out 10 cases.” 

AMA’s Medical Liability Claim Frequency Among U.S. Physicians report can be viewed here

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She began covering the medical imaging industry for Innovate Healthcare in 2021.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.